# Study of Longitudinal Plasma PD-L1 Testing With Immunotherapy in Lung Cancer

> **NCT06849518** · NA · RECRUITING · sponsor: **Ballad Health** · enrollment: 30 (estimated)

## Conditions studied

- Lung Cancer (NSCLC)

## Interventions

- **DIAGNOSTIC_TEST:** Circulogene liquid biopsy testing

## Key facts

- **NCT ID:** NCT06849518
- **Lead sponsor:** Ballad Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-11
- **Primary completion:** 2026-03-01
- **Final completion:** 2027-03-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06849518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06849518, "Study of Longitudinal Plasma PD-L1 Testing With Immunotherapy in Lung Cancer". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT06849518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*